Overview

A Taiwan Isoflavone Multicenter Study (TIMS)

Status:
Unknown status
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Consumption of soy-based foods is associated with a number of health benefits, including lower risk of cardiovascular disease, breast and prostate cancer, attenuated menopausal symptoms and prevention of bone loss with age. In order to investigate the effect of isoflavone on bone mineral density (BMD) and in Taiwan women with postmenopausal osteopenia, a Taiwan Isoflavone Multicentric Enrollment Study (TIMS) is designed.
Phase:
N/A
Details
Lead Sponsor:
National Health Research Institutes, Taiwan
Collaborators:
Genovate Biotechnology Co., Ltd.,
Taiwan Biotech Co., Ltd.